• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yahata Tamaki  八幡 環

ORCIDConnect your ORCID iD *help
… Alternative Names

YAHATA TAMAKI  八幡 環

Less
Researcher Number 90647562
Other IDs
Affiliation (Current) 2025: 和歌山県立医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2021 – 2023: 和歌山県立医科大学, 医学部, 助教
2018 – 2020: 和歌山県立医科大学, 医学部, 客員研究員
2017: 和歌山県立医科大学, 医学部, 学内助教
Review Section/Research Field
Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology
Keywords
Principal Investigator
PD-L1 / 卵巣癌 / IDO / AAV-CRISPR/Cas9 / アデノ随伴ウイルスベクター / AAV-CRISPR/Cas9 system / 婦人科学 / CRISPR/Cas9 system / CXCR4 / ケモカイン / CRISPR/Cas9
  • Research Projects

    (3 results)
  • Research Products

    (7 results)
  • Co-Researchers

    (4 People)
  •  免疫寛容誘導分子を標的とした卵巣癌におけるAAV-CRISPR/Cas9療法の確立Principal Investigator

    • Principal Investigator
      八幡 環
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Wakayama Medical University
  •  Novel gene therapy strategy for ovarian cancer using adeno-associated virus-CRISPR/Cas9Principal Investigator

    • Principal Investigator
      Yahata Tamaki
    • Project Period (FY)
      2020 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Wakayama Medical University
  •  Molecular pathological study of ovarian cancer using CRISPR/Cas9 system. "Targeting chemokines"Principal Investigator

    • Principal Investigator
      YAHATA TAMAKI
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Wakayama Medical University

All 2023 2022 2021 2019

All Journal Article Presentation

  • [Journal Article] Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9‐genome editing promotes antitumor immunity and suppresses ovarian cancer progression2019

    • Author(s)
      Yahata T, Mizoguchi M, Kimura A, Orimo T, Toujima S, Kuninaka Y, Nosaka M, Ishida Y, Sasaki I, Fukuda‐Ohta Y, Hemmi H, Iwahashi N, Noguchi T, Kaisho T, Kondo T, Ino K
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 4 Pages: 1279-1292

    • DOI

      10.1111/cas.13958

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07071, KAKENHI-PROJECT-18K10134, KAKENHI-PUBLICLY-17H05799, KAKENHI-PROJECT-17H04088, KAKENHI-PROJECT-17K19568, KAKENHI-PROJECT-19K07628, KAKENHI-PROJECT-18K16096, KAKENHI-PUBLICLY-19H04813, KAKENHI-PROJECT-17K11293, KAKENHI-PROJECT-17K16863
  • [Journal Article] Mabuchi Y, Takiguchi Y, Yahata T, Mizoguchi M, Sasaki N, Ota N, Minami S, Ino K. Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer.2019

    • Author(s)
      Mabuchi Y, Takiguchi Y, Yahata T, Mizoguchi M, Sasaki N, Ota N, Minami S, Ino K.
    • Journal Title

      Mol Clin Oncol.

      Volume: 10 Pages: 382-386

    • DOI

      10.3892/mco.2019.1806

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K16863
  • [Journal Article] Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing2019

    • Author(s)
      Iwahashi Naoyuki、Sakai Kazuko、Noguchi Tomoko、Yahata Tamaki、Matsukawa Hitomi、Toujima Saori、Nishio Kazuto、Ino Kazuhiko
    • Journal Title

      Scientific Reports

      Volume: 9 Issue: 1 Pages: 10426-10426

    • DOI

      10.1038/s41598-019-47030-w

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18677, KAKENHI-PROJECT-17K16863, KAKENHI-PROJECT-18K16776
  • [Presentation] Adeno associated virus-CRISPR/Cas9を用いた卵巣癌のPD-L1遺伝子を標的とした治療戦略2023

    • Author(s)
      八幡 環、西岡香穂、岩橋 尚幸、堀内優子、井箟一彦
    • Organizer
      第65回婦人科腫瘍学会学術講演会 2023
    • Data Source
      KAKENHI-PROJECT-23K08827
  • [Presentation] Adeno associated virus-CRISPR/Cas9を用いた卵巣癌のPD-L1遺伝子を標的とした治療戦略2023

    • Author(s)
      八幡 環、西岡香穂、岩橋 尚幸、堀内優子、井箟一彦
    • Organizer
      第65回婦人科腫瘍学会学術講演会 2023
    • Data Source
      KAKENHI-PROJECT-20K18171
  • [Presentation] Adeno associated virus-CRISPR/Cas9 mediated ovarian cancer treatment targeting PD-L1 gene in vivo2022

    • Author(s)
      Tamaki Yahata
    • Organizer
      第64回婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-20K18171
  • [Presentation] アデノ随伴ウイルス-CRISPR/Cas9を用いた卵巣癌のPD-L1遺伝子を標的とした新規遺伝子治療戦略2021

    • Author(s)
      八幡 環
    • Organizer
      第63回婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-20K18171
  • 1.  岩橋 尚幸 (50750907)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 2.  井箟 一彦 (60303640)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  邊見 弘明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 4.  野口 智子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi